MedTrace Logo

Pediatric Obesity Observational Prospective Trial

NCT03139877 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 295

Last updated 2021-06-18

No results posted yet for this study

Summary

Using an observational case-control cohort design, the investigator aims to define the mechanisms underlying microbiome regulation of metabolism in adolescence before and after medically indicated therapies for obesity. The investigator's overarching hypothesis is that gut bacteria control host weight, insulin sensitivity, and response to weight-loss treatments by modifying host metabolism.

Conditions

  • Pediatric Obesity

Sponsors & Collaborators

Principal Investigators

  • Sarah C Armstrong, MD · Duke University

Eligibility

Min Age
10 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-09-13
Primary Completion
2020-01-07
Completion
2020-01-07

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03139877 on ClinicalTrials.gov